{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:59:41Z","timestamp":1792159181716,"version":"4.4.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1097\/01.bor.0000240362.32089.4c","type":"journal-article","created":{"date-parts":[[2006,8,8]],"date-time":"2006-08-08T04:10:52Z","timestamp":1155010252000},"page":"503-506","source":"Crossref","is-referenced-by-count":32,"title":["Advances in the treatment of juvenile dermatomyositis"],"prefix":"10.1097","volume":"18","author":[{"given":"Elizabeth","family":"Stringer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210128","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1542\/pir.12-4-117","article-title":"Juvenile dermatomyositis: a clinical overview","volume":"12","author":"Pachman","year":"1990","journal-title":"Pediatr Rev"},{"key":"R2-12-20210128","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","article-title":"Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis","volume":"43","author":"Huber","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R3-12-20210128","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/rheumatology\/keg403","article-title":"Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis","volume":"42","author":"Ruperto","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"R4-12-20210128","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-3476(83)80706-9","article-title":"Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification","volume":"103","author":"Bowyer","year":"1983","journal-title":"J Pediatr"},{"key":"R5-12-20210128","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0022-3476(84)80012-8","article-title":"Course of treated juvenile dermatomyositis","volume":"105","author":"Spencer","year":"1984","journal-title":"J Pediatr"},{"key":"R6-12-20210128","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/000992288702601101","article-title":"Childhood dermatomyositis: clinical course and long-term follow-up","volume":"26","author":"Miller","year":"1987","journal-title":"Clin Pediatr (Phila)"},{"key":"R7-12-20210128","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0022-3476(96)70295-0","article-title":"Failure of pulse intravenous methylprednisolone treatment in juvenile dermatomyositis","volume":"128","author":"Lang","year":"1996","journal-title":"J Pediatr"},{"key":"R8-12-20210128","first-page":"621","article-title":"Long-term prognosis of patients with juvenile dermatomyositis initially treated with intravenous methylprednisolone pulse therapy","volume":"17","author":"Huang","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"R9-12-20210128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1529-0131(200012)13:6<360::AID-ART5>3.0.CO;2-Q","article-title":"The economic impact of intermittent high-dose intravenous versus oral corticosteroid treatment of juvenile dermatomyositis","volume":"13","author":"Klein-Gitelman","year":"2000","journal-title":"Arthritis Care Res"},{"key":"R10-12-20210128","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1090-3798(98)80021-4","article-title":"Childhood dermatomyositis: clinical course of 36 patients treated with low doses of corticosteroids","volume":"2","author":"Tabarki","year":"1998","journal-title":"Eur J Paediatr Neurol"},{"key":"R11-12-20210128","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/adc.51.7.494","article-title":"Treatment of dermatomyositis in childhood","volume":"51","author":"Dubowitz","year":"1976","journal-title":"Arch Dis Child"},{"key":"R12-12-20210128","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s100670050032","article-title":"Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate","volume":"19","author":"Al-Mayouf","year":"2000","journal-title":"Clin Rheumatol"},{"key":"R13-12-20210128","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mjd.2002.122196","article-title":"Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis","volume":"47","author":"Fisler","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R14-12-20210128","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/art.21378","article-title":"The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids","volume":"52","author":"Ramanan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R15-12-20210128","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00002281-199405000-00011","article-title":"Intravenous immunoglobulin therapy for rheumatic diseases","volume":"6","author":"Sany","year":"1994","journal-title":"Curr Opin Rheumatol"},{"key":"R16-12-20210128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0002-9343(91)90010-U","article-title":"Treatment of dermatomyositis with intravenous gammaglobulin","volume":"91","author":"Lang","year":"1991","journal-title":"Am J Med"},{"key":"R17-12-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/adc.72.1.25","article-title":"Intravenous immunoglobulin in juvenile dermatomyositis: four year review of nine cases","volume":"72","author":"Sansome","year":"1995","journal-title":"Arch Dis Child"},{"key":"R18-12-20210128","first-page":"2498","article-title":"Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety","volume":"27","author":"Al-Mayouf","year":"2000","journal-title":"J Rheumatol"},{"key":"R19-12-20210128","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/rheumatology\/keh082","article-title":"Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis: a review of efficacy and safety","volume":"43","author":"Riley","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"R20-12-20210128","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/art.10710","article-title":"Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial","volume":"48","author":"Lovell","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R21-12-20210128","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/art.21121","article-title":"Antitumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy","volume":"52","author":"Tse","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R22-12-20210128","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00002281-200311000-00003","article-title":"Cytokines in juvenile dermatomyositis pathophysiology: potential and challenge","volume":"15","author":"Uzel","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"R23-12-20210128","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000079547","article-title":"Treatment of dermatomyositis and polymyositis with antitumor necrosis factor-alpha: long-term follow-up","volume":"52","author":"Hengstman","year":"2004","journal-title":"Eur Neurol"},{"key":"R24-12-20210128","first-page":"S306","article-title":"Use of etanercept in chronic juvenile dermatomyositis (JDM).","volume":"46","author":"Miller","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R26-12-20210128","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","article-title":"Rituximab in the treatment of dermatomyositis: an open-label pilot study","volume":"52","author":"Levine","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R27-12-20210128","first-page":"S488","article-title":"A pilot study of rituximab therapy for refractory dermatomyositis.","volume":"46","author":"Levine","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R28-12-20210128","first-page":"S288","article-title":"Use of rituximab in refractory juvenile dermatomyositis.","volume":"52","author":"Endo","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R29-12-20210128","first-page":"1424","article-title":"Cyclosporin a therapy in refractory juvenile dermatomyositis: experience and longterm followup of 6 cases","volume":"23","author":"Zeller","year":"1996","journal-title":"J Rheumatol"},{"key":"R30-12-20210128","first-page":"2436","article-title":"Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis","volume":"24","author":"Reiff","year":"1997","journal-title":"J Rheumatol"},{"key":"R31-12-20210128","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00431-004-1497-7","article-title":"Steroid-sparing effect of tacrolimus in a patient with juvenile dermatomyositis presenting poor bioavailability of cyclosporine A","volume":"163","author":"Yamada","year":"2004","journal-title":"Eur J Pediatr"},{"key":"R33-12-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archderm.142.1.65","article-title":"Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis","volume":"142","author":"Edge","year":"2006","journal-title":"Arch Dermatol"},{"key":"R34-12-20210128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/09546630310018509","article-title":"Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study","volume":"15","author":"Hollar","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"R35-12-20210128","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000079903","article-title":"Topical tacrolimus in cutaneous lesions of dermatomyositis: lack of effect in side-by-side comparison in five patients","volume":"209","author":"Garcia-Doval","year":"2004","journal-title":"Dermatology"},{"key":"R36-12-20210128","first-page":"2152","article-title":"Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis","volume":"23","author":"Oliveri","year":"1996","journal-title":"J Rheumatol"},{"key":"R37-12-20210128","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1346-8138.1993.tb01338.x","article-title":"Calcinosis cutis in juvenile dermatomyositis responsive to aluminum hydroxide treatment","volume":"20","author":"Nakagawa","year":"1993","journal-title":"J Dermatol"},{"key":"R38-12-20210128","first-page":"1129","article-title":"Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications","volume":"28","author":"Harel","year":"2001","journal-title":"J Rheumatol"},{"key":"R39-12-20210128","first-page":"1837","article-title":"Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy","volume":"32","author":"Ambler","year":"2005","journal-title":"J Rheumatol"},{"key":"R40-12-20210128","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/art.21332","article-title":"Quantitative assessments of the effects of a single exercise session on muscles in juvenile dermatomyositis","volume":"53","author":"Maillard","year":"2005","journal-title":"Arthritis Rheum"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00124743-200608001-00179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:45:17Z","timestamp":1785858317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-200609000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.bor.0000240362.32089.4c","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}